The acquisition of Nimble is in line with AbbVie's mission to discover and deliver innovative medicines and solutions for serious health issues and medical challenges of the future.

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

AbbVie's growth prospects remain strong despite the impending decline in revenue from Humira. Click here to read more on why I rate ABBV stock as a Buy.

We’ve gone through blood, sweat, and tears to get here. This validates everything we’ve built,' Saldanha says as Glenmark ...

AbbVie ends a six-day losing streak with a 0.88% gain, though concerns over increased R&D costs and earnings revisions continue to weigh on investor sentiment.

AbbVie Inc . (NYSE: ABBV), a leading biopharmaceutical company with a market capitalization of $375 billion, has been navigating a complex landscape of challenges and opportunities as it transitions ...

AbbVie and Alphabet spin-out Calico Life Sciences have agreed to fund their seven-year-old partnership seeking treatments for diseases of ageing with another $500 million apiece. The collaboration ...

Advance backing of early-stage programs is allowing AbbVie to apply a streamlined approach to support the growth of transformative science, people, and ecosystems.

AbbVie on Thursday lowered its forecast for 2024 adjusted profit, citing the impact of $82 million in milestones, and research and development expenses related to acquisitions. The drugmaker ...